Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2024 07:45 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults

Plasma levels of inflammasome ASC show promise as a biomarker of early cognitive decline in older adults.
January 03, 2024 09:46 ET | Source: Spherix Global Insights

US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority

EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Huntington’s disease (HD) could be called the perfect storm of neurodegenerative diseases. It causes a loss of critical striatal neurons which affect not...
November 01, 2023 09:26 ET | Source: American Academy of PAs

AAPA, PA Foundation, Cleveland Clinic, and Davos Alzheimer’s Collaborative Release Early Cognitive Assessment Toolkit

ALEXANDRIA, VA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), PA Foundation (PAF), Cleveland Clinic, and Davos Alzheimer’s Collaborative (DAC) today publicly...
June 28, 2023 10:59 ET | Source: American Academy of PAs

Collaborative AAPA, PA Foundation, Cleveland Clinic Alzheimer’s Early Detection Project Moves into Pilot Phase

Alexandria, VA, June 28, 2023 (GLOBE NEWSWIRE) -- Last year, the American Academy of PAs (AAPA), the PA Foundation, and Cleveland Clinic were awarded a grant from the Davos Alzheimer’s Collaborative...
June 13, 2022 09:00 ET | Source: Vaga

VAGA Helps People Suffering with Poor Mental Health or Cognitive Decline Through Art Therapy

New York, June 13, 2022 (GLOBE NEWSWIRE) -- Mental health is a topic that has been under the spotlight in recent years, as people are realising that it is just as important as physical health and...
April 25, 2022 09:00 ET | Source: Persistence Market Research

Cognitive Decline Market is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031)

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to...
December 20, 2017 08:00 ET | Source: Posit Science

Don’t Surrender to Cognitive Aging and Dementia

SAN FRANCISCO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Dr. Henry Mahncke, CEO of Posit Science, commented on a group of review articles published yesterday, which claimed no intervention of any kind has...